معلومات مباشر
معلومات مباشر
Ready to play
Ready to play
Nadine Medical Company’s profits declined by 9.73% year-over-year in the second quarter of 2026, recording a net profit of 215.2 million SAR compared to 238.4 million SAR in the same period last year. Despite the decline in profits, total gross profit increased by 4.3% to 1,007.6 million SAR, driven by higher sales across key sectors, although the gross profit margin narrowed to 37.7%. Operating profit reached 245.9 million SAR, down 5.7% due to increased operational expenses resulting from ongoing investments in growth and expansion within the healthcare sector and e-commerce platforms. In the first half of the year, the company's profits decreased to 451 million SAR from 493.6 million SAR in the same period last year, reflecting an 8.65% increase.
Notice: This Is an AI-Generated Summary
Comments (0)